Stocktoria
MANNATECH INC MTEX
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1999-02-16
MANNATECH INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $108.0M | $117.9M | $132.0M | $137.2M | $159.8M |
| Gross profit | $81.0M | $91.5M | $102.9M | $104.1M | $125.6M |
| R&D expense | $800,000 | $700,000 | $800,000 | $1.0M | $1.2M |
| SG&A expense | $39.7M | $41.7M | — | — | — |
| Operating income | -$426,000 | $1.4M | -$964,000 | -$405,000 | $9.0M |
| Income tax | $12.3M | $1.2M | $1.1M | $4.0M | -$950,000 |
| Net income | -$15.2M | $2.5M | -$2.2M | -$4.5M | $9.8M |
| EPS (diluted) | $-8.00 | $1.32 | $-1.20 | $-2.35 | $4.71 |
| Operating cash flow | -$3.0M | $2.3M | -$2.4M | -$2.6M | $10.8M |
| Free cash flow | -$4.3M | $2.0M | -$3.1M | -$3.7M | $10.1M |
| Cash & equivalents | $6.2M | $11.4M | $7.7M | $13.8M | $24.2M |
| Inventory | $10.1M | $10.4M | $14.5M | $14.7M | $12.0M |
| Total assets | $30.0M | $36.1M | $41.2M | $49.1M | $59.6M |
| Total liabilities | $35.2M | $27.4M | $30.7M | $35.0M | $35.2M |
| Shareholders' equity | -$5.2M | $8.6M | $10.5M | $14.2M | $24.4M |
Source: SEC EDGAR filings · CIK 0001056358 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.